Magnesium at physiological pregnancy and at its complications

Lierature review

Authors

DOI:

https://doi.org/10.18370/2309-4117.2023.69.41-52

Keywords:

magnesium, functions of magnesium, deficiency of magnesium, association with calcium, pregnancy, pregnancy complications

Abstract

Sources of literature on the role of the trace element magnesium and the assosiation with calcium in physiological processes in the body of reproductive aged women and pregnant women, the importance of its main functions and role in preventing the main pregnancy complications were analyzed.

Magnesium is the fourth most important extracellular cation after sodium, potassium and calcium and the second intracellular cation in importance after potassium. Many researchers have proven the participation of magnesium in almost everyone important functions in the body. Magnesium performs the following functions which are closely interconnected: metabolic, energetic, enzymatic, cardiovascular, antithrombotic, vascular, neuroprotective, structural, is an antagonist of calcium and an agonist of NMDA receptors. Magnesium realizes its functions in close interaction with cations of sodium, potassium and calcium. It acts as a calcium antagonist. It should be noted attention to the understanding of the interaction of divalent cations-competitors of magnesium and calcium. Calcium has complex influences on interaction of magnesium with blood proteins, reduces its concentration, which can affect physiological processes during pregnancy and in non-pregnant women.

Today, magnesium is used only for prevention and treatment of eclampsia, in which anticonvulsants are commonly used ineffective. It can be assumed that different convulsive states have different intracellularly or extracellularly magnesium concentration is important in the pathogenesis and occurrence of eclampsia. Determination of magnesium concentration never was indicated in the recommendations for the management of preeclampsia. Magnesium use is insufficiently substantiated in cases of uterus contraction activity in any conditions (threat of abortion, premature birth) and prevention of pathological blood clot formation (as causes of multiple complications of pregnancy), neuroprotective effect on a child.

The role of magnesium in the production of steroid hormones has been proven. However, this effect remains unrealized in obstetrics and gynecology practice.

Data from literature sources given in the article help justify the use of magnesium and analyze its interaction with calcium during pregnancy.

Author Biographies

V.F. Nagorna, Odesa National Medical University, Odesa

MD, professor, Department of Obstetrics and Gynecology

T.A. Kulish, Odesa National Medical University, Odesa

Intern in obstetrics and gynecology, Department of Obstetrics and Gynecology

References

  1. Complications of pregnancy: hypertension in pregnancy. King Edward Memorial Hospital (2016). Available from: [https://www.kemh.health.wa.gov.au/~/media/HSPs/NMHS/ Hospitals/WNHS/Documents/Clinical-guidelines/Obs-Gyn- Guidelines/Hypertension-in-Pregnancy-Medical-Management. pdf?thn=0], last accessed Oct 19, 2023.
  2. The management of severe pre-eclampsia/eclampsia. Royal college of obstetricians and gynaecologists (2010). Available from: [http://79.170.40.175/isshp.com/wp-content/ uploads/2014/05/rcog.pdf], last accessed Oct 19, 2023.
  3. Smith, J. M., Lowe, R. F., Fullerton, J., et al. “An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.“ BMC pregnancy and childbirth (2013). DOI: 10.1186/1471-2393-13-34.
  4. Savustyanenko, A.V. “Magnesium in the prevention of complicated pregnancy”. News of medicine and pharmacy. Obstetrics and Gynecology (2016); 587: 7–10.
  5. Grober, U., Schmidt, J., Kisters, K. “Magnesium in prevention and therapy.” Nutrients 7.9 (2015): 8199–226.
  6. Lebedev, V.A., Pashkov, V.M., Budanov, P.V. “Clinical significance of magnesium deficiency in women with premenstrual syndrome.” Issues of gynecology, obstetrics and perinatology 7.1 (2008): 77–82.
  7. Spiridonova, N.V., Basina, E.I., Krylova, O.V. “Comparative effectiveness of various treatment regimens for menopausal disorders.” Obstetrics, Gynecology and Reproduction 6.3 (2012): 49–55.
  8. Pestrikova, T.Yu., Yurasova, E.A., Yurasov, I.V. “The biological role of magnesium deficiency in disruption of homeostasis in women: a review of the literature.” Gynecology 18.2 (2016): 63–66.
  9. Gromova, O. A., & Torshin, I. Yu. “Magnesium and pyridoxine: basic knowledge.” (2006): 230.
  10. Dizhevskaya, E. V. “Multidisciplinary approach to the correction of magnesium deficiency conditions.” Obstetrics, Gynecology and Reproduction (2025); 9(3): 68–85.
  11. Andrianova, M.Yu., Dementieva, I.I., Maltseva, A.Yu. “Magnesium and its balance.” Anesthesiology and resuscitation 6 (1995): 73–76.
  12. Dadak, K. “Magnesium deficiency in obstetrics and gynecology.” Obstetrics, Gynecology and Reproduction 7.2 (2013): 6–14.
  13. Balan, V. E., Zhuravel, A. S., Tikhomirova, E. V., Panina, E. M., & Ovchinnikova, V. V. “Modern view on the need to correct magnesium deficiency during pregnancy.” Medical Council 20 ( 2017): 198–202.
  14. Gromova, O.A. “Magnesium deficiency as a problem of modern nutrition in children and adolescents.” Pediatric Pharmacology 11.1 (2014): 20–30.
  15. Ogoma, Y., Kobayashi, H., Fujii, T., et al. “Binding study of metal ions to S100 protein: 43Ca, 25Mg, 67Zn and 39K nmr.” International journal of biological macromolecules 14.5 (1992): 279–286.
  16. Bruno, V., Sortino, M. A., Scapagnini, U., et al. “Antidegenerative effects of Mg (2+)-valproate in cultured cerebellar neurons.” Functional neurology 10.3 (1995): 121–130.
  17. Prilepskaya, V.N., Mezhevitinova, E.A., Sasunova, R.A., & Ivanova, E.V. “The role of magnesium in the pathogenesis of premenstrual syndrome.” Russian Bulletin of Obstetrician-Gynecologist 12.3 (2012): 81–87.
  18. Khashukoeva, A. Z., Khlynova, S. A., Khashukoeva, Z. Z., & Karelina, L. A. (2015). “The role of magnesium in a woman’s life.” Lechashchyy vrach 3 (2015).
  19. Dadak, K., Makatsaria, A. D., Blinov, D. V., & Zimovina, U. V. “Clinical and biochemical aspects of the use of magnesium preparations in obstetrics, gynecology and perinatology.” Obstetrics, Gynecology and Reproduction 8.2 (2014): 69–78.
  20. Resolution of the III International Expert Council on the problems of magnesium deficiency in obstetrics and gynecology. Obstetrics and gynecology 12 (2015): 153.
  21. Khashukoeva, A. Z., Khlynova, S. A., Khashukoeva, Z. Z., & Karelina, L. A. “The role of magnesium in a woman’s life.” (2015)
  22. Gromova, O. A., Torshin, I. Yu., & Yurgel, I. S. “Retrospective pharmacokinetic studies of magnesium drugs.” Difficult Patient 7.6–7 (2009): 42–46.
  23. Gromova, O. A., Volkov, A. Yu., Glagovsky et al. “Dynamics of magnesium concentration in the blood after taking various magnesium-containing drugs.” Pharmatheka 10 (2009): 63–68.
  24. Zimmermann, K., Lennerz, J. K., Hein, A., et al. “Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system.” Proceedings of the National Academy of Sciences. 108.44 (2011): 18114–19.
  25. Gromova, O.A., Serov, V.N., & Torshin, I.Yu. “Magnesium in obstetrics and gynecology: history of use and modern views.” Difficult Patient 6.8 (2008): 20–28.
  26. Seelig, M.S. “Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review).” Journal of the American College of Nutrition 13.5 (1994): 429–446.
  27. Cruikshank, D.P., Pitkin, R.M., Donnelly, E., & Reynolds, W.A. “Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion.” Obstetrics & Gynecology 58.4 (2018): 430–434.
  28. Budanova, M. V., Aslanova, P. A., & Budanov, P. V. “Clinical manifestations and effects of correction of magnesium deficiency in children.“ Difficult Patient 7. 1–2 (2009): 50–4.
  29. Elrod, J.W., Wong, R., Mishra, S., et al. “Cyclophilin D controls mitochondrial pore–dependent Ca 2+ exchange, metabolic flexibility, and propensity for heart failure in mice.” The Journal of clinical investigation 120.10 (2010): 3680–7.
  30. Belenichev, I. F. Neuroprotection and neuroplasticity. I. F. Cherniy, V. I. Nagornaya. К. Logos. (2015).
  31. Meldrum, B.S. “Glutamate as a neurotransmitter in the brain: review of physiology and pathology.” The Journal of nutrition 130.4 (2000): 1007S–1015S.
  32. Gromova, O.A., Torshin, I.Yu., Tomilova, I.K., et al. “Potassium, magnesium and pyridoxine in the context of the biological effects of estrogens.” Gynecology 19.3 (2017): 30–39.
  33. Dicke, G.B. ”Myths and facts about the use of magnesium in obstetric practice.” Obstetrics, Gynecology and Reproduction 11.3 (2017): 59–68.
  34. Fofanova, I.Yu. “Magnesium deficiency and its connection with obstetric pathology.” Medical Council 5 (2013) 102–109.
  35. Kuznetsova, I.V. “Possibilities of non-hormonal correction of menstrual disorders.” Medical Council 13 (2019): 16–27.
  36. Boston, J.L., Beauchene, R.E., & Cruikshank, D. P. “Erythrocyte and plasma magnesium during teenage pregnancy: relationship with blood pressure and pregnancyinduced hypertension.” Obstetrics & Gynecology 73.2 (1989): 169–174.
  37. Kisters, K., Korner, J., Louwen, F., et al. “Plasma and membrane Ca2+ and Mg2+ concentrations in normal pregnancy and in preeclampsia.” Gynecologic and obstetric investigation 46.3 (1998): 158–163. 38.
  38. Resnick, L.M., Barbagallo, M., Bardicef, M., et al. “Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: a nuclear magnetic resonance spectroscopic study.” Hypertension 3 (2004): 322–326.
  39. Jain, S., Sharma, P., Kulshreshtha, S., et al. “The role of calcium, magnesium, and zinc in pre-eclampsia.” Biological trace element research 133 (2010): 162–170.
  40. Ugwuja, E.I., Famurewa, A.C., & Ikaraoha, C.I. “Comparison of serum calcium and magnesium between preeclamptic and normotensive pregnant Nigerian women in Abakaliki, Nigeria.” Annals of medical and health sciences research 6.1 (2016): 33–37.
  41. Kolisek, M., Galaviz-Hernandez, C., Vazquez-Alaniz, F., et al. ”SLC41A1 is the only magnesium responsive gene significantly overexpressed in placentas of preeclamptic women.” Hypertension in pregnancy (2013); 32(4): 378–389.
  42. Kovacs, L., Molnar, B.G., Huhn, E., & Bodis, L. “Magnesiumsubstitution in der Schwangerschaft.“ Geburtshilfe und Frauenheilkunde 48.08 (1988): 595–600.
  43. Arikan, G., Gucer, F., Scholl, W., & Weiss, P.A.M. “Fruhgeburtlichkeit unter oraler Magnesiumsubstitution bei unkomplizierten Schwangerschaften.” Geburtshilfe und Frauenheilkunde 57.09 (1997): 491–495.
  44. Spatling, L., & Spatling, G. “Magnesium supplementation in pregnancy. A doubleblind study.” BJOG: An International Journal of Obstetrics & Gynaecology 95.2 (1988): 120–125.
  45. Li, S., & Tian, H. “Oral low-dose magnesium gluconate preventing pregnancy induced hypertension.” Zhonghua Fu Chan Ke Za Zhi 32.10 (1997): 613-615.
  46. Ogoma, Y., Kobayashi, H., Fujii, T., et al. “Binding study of metal ions to S100 protein: 43Ca, 25Mg, 67Zn and 39K nmr.” International journal of biological macromolecules 14.5 (1992): 279–286.
  47. Bain, E.S., Middleton, P.F., & Crowther, C.A. “Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.” BMC pregnancy and childbirth 13.1 (2013): 1–31.
  48. Nosenko, O. M.; Hancza, F. O. “Magnesium in the prevention of gestational complications in women due to gestation induced in the DRT cycle.” Reproductive endocrinology 6.56 (2020): 81–87.
  49. Marushko, Yu.V. “Priming of magnesium preparations in pediatric practice (review of the literature).” Today’s pediatrics 6.78 (2016): 27–32.
  50. Shurpyak, S.O. “Somatic and obstetric aspects of magnesium deficiency (Clinical lecture).” Healthy women 8.114 (2016): 10–17.
  51. Resolution of the III International Expert Council on the problems of magnesium deficiency in obstetrics and gynecology. Obstetrics and gynecology 12 (2015): 153.
  52. McDonald, S.D., Lutsiv, O., Dzaja, N., & Duley, L. “A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.” International Journal of Gynecology 118.2 (2012): 90–96.
  53. Makrides M. “DHA supplementation during the perinatal period and neurodevelopment: Do some babies benefit more than others? Prostaglandins Leukot Essent Fatty Acids.” 88.1 (201387–90. DOI: 10.1016/j.plefa.2012.05.004.
  54. Schlegel, R. N., et al. “Maternal hypomagnesemia alters hippocampal NMDAR subunit expression and programs anxiety-like behaviour in adult offspring.” Behavioural Brain Research 328 (2017); 39–47.
  55. Jahnen-Dechent, Wilhelm, and Markus Ketteler. «Magnesium basics.» Clinical kidney journal 5.Suppl_1 (2012): і3–і14.
  56. Geiger, Helmut, and Christoph Wanner. «Magnesium in disease.» Clinical kidney journal 5.Suppl_1 (2012): i25–i38.
  57. Euser, Anna G., and Marilyn J. Cipolla. «Magnesium sulfate for the treatment of eclampsia: a brief review.» Stroke 40.4 (2009): 1169–1175.
  58. Li, S. and Tian, H. “Oral Low Dose Magnesium Gluconate Preventing Pregnancy Induced Hypertension.“ Chang Hua Fu Chan Ko Tsa Chih 32 (1997): 613–615. 9642379
  59. Makrides, M., Crosby, D., Bain, E., A Crowther, C. “Magnesium supplementation in pregnancy.” Cochrane Database Syst Re. Apr 3 (2014). DOI: 10.1002/14651858.CD000937.pub2

Downloads

Published

2023-09-29

How to Cite

Nagorna, V., & Kulish, T. (2023). Magnesium at physiological pregnancy and at its complications: Lierature review. REPRODUCTIVE ENDOCRINOLOGY, (69), 41–52. https://doi.org/10.18370/2309-4117.2023.69.41-52

Issue

No. 69 (2023)

Section

Pregnancy and childbirth

License

Copyright (c) 2023 В.Ф. Нагорна, Т.А. Куліш

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.